KOAA Survey: Does the pausing of the J&J vaccine change your plans?
KOAA
and last updated 2021-04-13 11:09:01-04
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) recommended a pause in the use of Johnson & Johnson s COVID-19 vaccine out of an abundance of caution on Tuesday.
In a series of tweets Tuesday morning, the FDA said it was recommending a pause after receiving reports that six people developed rare and severe blood clots after receiving the vaccine. So far, nearly 7 million Americans have received a dose of the Johnson & Johnson vaccine.
During Tuesday morning s press conference, acting FDA commissioner Dr. Janet Woodcock said the review would take a matter of days but could extend longer depending on what we learn. Dr. Anne Schuchat, the principal director of CDC, added that the pause was taking place in order to better prepare the health system in the event more patients experience clotting.